Lord, Abbett & Co. LLC

SEC CIK: 0000728100
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overview All 13F holders of AMLX Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of AMLX by Lord, Abbett & Co. LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−244,493−100.0%	Sold out	Holders
Q2 2023	244,493	$5.27M	<0.1%	−5,549−2.2%	Reduced	Holders
Q1 2023	250,042	$7.34M	<0.1%	+250,042	New	Holders